European Cancer Summit 2020

Working Together Against Cancer: Breaking Down Barriers & Saving Lives

The virtual European Cancer Summit 2020 on 18 & 19 November brought together leading oncology experts, patient advocates, politicians and policy-makers to discuss the main issues impacting cancer policy, for the benefit of cancer patients, healthcare professionals and all people across Europe. 

 

You can view the European Cancer Organisation hub year-round, with links to the hubs of our Member Societies, Patient Advocacy Groups and Community 365 open until the end of January. Please click here.

 

SAVE THE DATE:
The European Cancer Summit 2020 will take place on 17 & 18 November 2021!

 

18 November 2020 9:00 - 18:00 CET 19 November 2020 9:00 - 18:15 CET

Virtual Edition

This year, the European Cancer Summit is more important than ever. The COVID-19 crisis has impacted health care systems and workforces across the world, not least on the resources normally dedicated to cancer early detection and treatment. Citizens with concerns about cancer have been more reluctant to engage with healthcare professionals for fear of catching the virus. Cancer workforces and facilities have been redeployed to deal with the crisis, not always with the right level of protection and support.

And at the same time, two important European cancer initiatives have been under development. Europe’s Beating Cancer Plan, launched on 4 February at the EU Parliament, and the EU Cancer Mission have both been consulting on their plans and looking for medical expertise and patient experience.

So this year, the stage is set for very interesting discussions on a number of topics, prioritised by our member societies as the most important areas of collaboration across disciplines and professions within the @EuropeanCancer family. 

The webcasts from our 2019 European Cancer Summit are available here and the Report is available here.

High-Level Speakers

We have leading speakers and panellists confirmed and you can see the full gallery of who is joining us "on stage" here.

Sessions with Relevance & Impact

Our Summit includes sessions on the EU Cancer Mission, Europe’s Beating Cancer Plan; Cancer Issues Worldwide, the Impact of COVID-19 on Cancer; as well as the subjects covered by our Focused Topic Networks. See our final programme here .

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired Past-President, Union for International Cancer Control, Jordan
  • Manuel Heitor Minister for Science, Technology and Higher Education, Portugal
  • Anja Karliczek Federal Minister of Education and Research, Germany
  • Simona Kustec Minister of Education, Science and Sport, Slovenia

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired Past-President, Union for International Cancer Control, Jordan
  • Manuel Heitor Minister for Science, Technology and Higher Education, Portugal
  • Anja Karliczek Federal Minister of Education and Research, Germany
  • Simona Kustec Minister of Education, Science and Sport, Slovenia
  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired Past-President, Union for International Cancer Control, Jordan
  • Manuel Heitor Minister for Science, Technology and Higher Education, Portugal Read Bio
  • Anja Karliczek Federal Minister of Education and Research, Germany Read Bio
  • Simona Kustec Minister of Education, Science and Sport, Slovenia Read Bio
  • Mariya Gabriel European Commissioner for Innovation, Research, Culture, Education and Youth
  • Hans Kluge WHO Regional Director for Europe Read Bio
  • Nicolas Schmit European Commissioner for Jobs and Social Rights Read Bio
  • Bente Mikkelsen Director, Non-communicable Diseases, World Health Organization Read Bio
  • Walter Ricciardi Chair of the EU Cancer Mission Read Bio
  • Véronique Trillet-Lenoir MEP Rapporteur, Special Committee on Beating Cancer, Shadow Rapporteur, EU4Health; Member, EU Special Committee on Beating Cancer; Member, ENVI Committee and Co-Chair of MEPs Against Cancer, Oncologist
  • Manfred Weber MEP Chairman, EPP Group in the European Parliament
  • Dolors Montserrat MEP Member, EU Special Committee on Beating Cancer and Co-Chair, ENVI Committee Health Working Group and Former Spanish Health Minister Read Bio
  • Bartosz Arłukowicz MEP Chairman of the Special Committee on Beating Cancer Read Bio
  • Sara Cerdas MEP Shadow Rapporteur, EU4Health; Vice Chair of the Special Committee on Beating Cancer and Co-Chair, ENVI Committee Health Working Group
  • Janina Ochojska MEP Member, Committee on Development
  • Frances Fitzgerald MEP Member, Committee on Economic and Monetary Affairs Read Bio
  • Nicolás González MEP Member of the Special Committee on Beating Cancer Read Bio
  • Alessandra Moretti MEP Member, Special Committee on Beating Cancer Read Bio
  • Kateřina Konečná MEP Member of the Special Committee for Beating Cancer Read Bio
  • Andrea Ammon Director, European Centre for Disease Prevention and Control Read Bio
  • Christine Chomienne Vice Chair of the EU Cancer Mission Read Bio
  • Bettina Ryll EU Cancer Mission Board Member and Founder, Melanoma Patient Network Europe
  • Lori Pierce President, American Society of Clinical Oncology
  • John F Ryan Director, Public Health, Country Knowledge and Crisis Management, DG SANTE Read Bio
  • Regina Beets-Tan EU Cancer Mission Board Member, Member of the European Cancer Organisation Executive Committee, Digital Health Network Co-Chair
  • Thierry Philip EU Cancer Mission Assembly Member and President, Organisation of European Cancer Institutes Read Bio
  • Franco Cavalli Chair, World Oncology Forum and President, Foundation for the Institute of Oncology Research
  • Partha Basu Head, Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer, World Health Organization Read Bio
  • Tit Albreht Coordinator, Joint Action innovative Partnership for Action Against Cancer
  • Anja Mehnert Head of Psychosocial Oncology, Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig Read Bio
  • Francesca Colombo Head of the Health Division at the Organisation for Economic Co-operation and Development Read Bio
  • Richard Sullivan Editor-in-Chief, Journal of Cancer Policy, and Director, Institute of Cancer Policy, King's College London Read Bio
  • Masum Hossain President, International Developed Markets, Pfizer
  • Tristan Almada Co-Founder, HPV and Anal Cancer Foundation and the NOMAN is an Island: Race to End HPV Campaign Read Bio
  • Alexander Zehnder Global Head of Oncology, Sanofi
  • Matti Aapro President, European Cancer Organisation and EU Cancer Mission Assembly Member Read Bio
  • Isabel Rubio Co-Chair of the European Cancer Summit 2020, Board Member of the European Cancer Organisation, Prevention Network Co-Chair Read Bio
  • Stefan Gijjsels Co-Chair of the European Cancer Summit 2020 and Co-Chair of the European Cancer Organisation's Patient Advisory Committee Read Bio
  • Sema Erdem Co-Chair, European Cancer Organisation's Patient Advisory Committee Read Bio
  • Philip Poortmans Past-President, European Cancer Organisation and Quality Cancer Care Network Co-Chair Read Bio
  • Wim Oyen Treasurer, European Cancer Organisation and Digital Health Network Co-Chair Read Bio
  • Dominique de Valeriola Member, European Cancer Organisation Executive Committee
  • Denis Lacombe European Cancer Organisation Health Systems and Treatment Optimisation Network Co-Chair
  • Yolande Lievens European Cancer Organisation Health Systems and Treatment Optimisation Network Co-Chair
  • Caroline Dive President, European Association for Cancer Research
  • Margaret Stanley President, International Papillomavirus Society
  • Catherine Owen Senior Vice President, Major Markets, Bristol-Myers Squibb Read Bio
  • Nicoletta Luppi Senior Vice President and Managing Director, MSD Italia Read Bio
  • Simon Oberst European Cancer Organisation Quality Cancer Care Network Co-Chair
  • Mirjam Crul Board Member, European Cancer Organisation, Special Network on the Impact of COVID-19 on Cancer Co-Chair and Workforce Network Co-Chair Read Bio
  • Mark Lawler Board Member, European Cancer Organisation and Special Network on the Impact of COVID-19 on Cancer Co-Chair Read Bio
  • Nathalie Moll Director General, European Federation of Pharmaceutical Industries and Associations
  • Andreas Charalambous European Cancer Organisation Workforce Network Co-Chair
  • Padraic Ward Head of Commercial Operations, Roche Read Bio
  • Kathy Oliver Vice-Chair, European Cancer Organisation's Patient Advisory Committee
  • Peter Lührs Therapeutic Area Head Oncology, Bayer Read Bio
  • Daniel Kelly European Cancer Organisation HPV Action Network Co-Chair
  • Rui Medeiros European Cancer Organisation HPV Action Network Co-Chair
  • Hein Van Poppel European Cancer Organisation Inequalities Network Co-Chair
  • Nicolò Battisti European Cancer Organisation Inequalities Network Co-Chair
  • Andrew Davies European Cancer Organisation Survivorship and Quality of Life Network Co-Chair
  • Csaba Dégi Board Member, European Cancer Organisation and Survivorship and Quality of Life Network Co-Chair Read Bio
  • Robert Greene Member, European Cancer Organisation's Patient Advisory Committee Read Bio
  • Šarūnas Narbutas Chairman, Youth Cancer Europe
  • Jan Van Meerbeeck Board Member, European Cancer Organisation and Prevention Network Co-Chair Read Bio
  • Jan Geissler EU Cancer Mission Assembly Member and Member of the European Cancer Organisation's Patient Advisory Committee Read Bio
  • Françoise Meunier Vice President, Federation of European Academies of Medicine Read Bio
  • Geerard Beets European Cancer Organisation Workforce Network Co-Chair
  • Cobi Reisman Past-President, European Society of Sexual Medicine Read Bio
  • Harry de Koning Deputy Head, Public Health and Screening Evaluation, Department of Public Health, Erasmus MC Read Bio
  • Gilliosa Spurrier Member, European Cancer Organisation's Patient Advisory Committee, Chair, WECAN and Member, Melanoma Patient Network Europe Read Bio
  • Fred Prior Professor and Chair, Department of Biomedical Informatics, Professor of Radiology, University of Arkansas for Medical Sciences
  • Alexandru Eniu Deputy Scientific Director, European School of Oncology and Senior Medical Oncologist, Breast Cancer Tumor Lead, Hopital Riviera-Chablais
  • Emilie Karafillakis European Research Lead, Vaccine Confidence Project, London School of Hygiene and Tropical Medicine Read Bio
  • Kathi Apostolidis President, European Cancer Patient Coalition
  • Katherine Reeder-Hayes Chair, Health Equity Committee, American Society of Clinical Oncology
  • Wiro Niessen Principal Investigator, Radiology & Nuclear Medicine, Erasmus MC
  • Lynda Wyld Professor, Surgical Oncology, Department of Oncology and Metabolism, The University of Sheffield Read Bio
  • Lydie Meheus Managing Director, Anticancer Fund Read Bio
  • Bengt Jönsson Professor Emeritus of Health Economics, Stockholm School of Economics, Sweden Read Bio
  • Benjamin Besse Professor of Medical Oncology, Paris-Saclay University, France Read Bio
  • Anastassia Negrouk Chief Operating Officer, MyData-TRUST Read Bio
  • Christian Stoeckigt Head of Scientific Affairs & Medical Education, Hologic

The European Cancer Summit is much more than a coming-together of leaders in the cancer policy field. By forming high level resolutions on the organisation of cancer care, the Summit represents an important ‘working together’ of diverse stakeholder interests, creating and expressing new consensus on the change required within European health systems to deliver the best care to cancer patients.

Simply returning to pre COVID-19 cancer systems is not an option. We must urgently address the COVID-19 induced backlog in all aspects of cancer control and build back better cancer care delivery systems for European citizens and patients. ​

European Cancer’s New Normal must deliver more resilient cancer systems that: ​

1. Urgently address the cancer backlog ​

2. Restore confidence of European citizens and patients in cancer health services

3. Tackle medicines, products and equipment shortages​

4. Address cancer workforce gaps across the European continent​

5. Employ innovative technologies to strengthen cancer systems and provide optimal care to cancer patients​

6. Embed data collection and the rapid deployment of cancer intelligence to enhance policy delivery​

7. Secure deeper pan-European health cooperation​

Cancer must not become the Forgotten “C” in the Fight against COVID-19.

Research in cancer care should address questions relevant and meaningful for patients and public health. Such research should follow an independent process to support optimal access for patients to evidence-based multidisciplinary cancer treatment.

To achieve this, a reorientation of health systems and research approaches in cancer is needed. This requires addressing gaps in clinical and health services research applied to cancer through a reverse engineering approach, starting with better definition of the important clinical and public health questions.

Europe's Beating Cancer Plan must address huge inequalities across Europe, between and within countries.

A powerful means to raise the bar is a European Cancer Dashboard, including the European Code of Cancer Practice, to report key metrics and ensure quality cancer care.

It's time to take European cooperation on cancer screening to the next level. The European Cancer community recommends:

  • An evidence-led update to the 2003 EU Screening recommendations including dedicated consideration of screening policies for tumour types such as lung & prostate cancer.
  • A European Cancer Dashboard that monitors screening coverage and quality performance.
  • A European Platform for screening agencies to facilitate rapid best practice-sharing.
  • EU research initiatives supporting screening related policy needs, such as new behavioural research insights, impact assessment, the application of risk stratification approaches, and how to examine and assess new screening options.

The European Cancer Community awaits the publication of Europe’s Beating Cancer Plan with eager anticipation, and in the time remaining before its publication, reminds of the need to:

  • Set inspiring goals and ambitions
  • Monitor the implementation and the impact of the Plan with the support of Member States and the Cancer Community
  • Ensure attention within the Plan pillars on matters such as: inequalities, the oncology workforce, the research landscape, co-morbidities, patient empowerment and health literacy
  • Avoid “reinventing the wheel” by working together with all cancer stakeholders across the EU for a successful implementation of Europe’s Beating Cancer Plan

Ensuring the access of cancer patients to specialised multi-professional care should be as high a priority for countries, and international organisations such as the EU and WHO, as ensuring patient access to products and technologies.

Therefore, a fundamental tool for the delivery of EU ambitions on improving cancer care should be the Professional Qualifications Directive. The Directive should be proactively deployed to support specialisms in cancer care in harmonising education and training requirements and increasing the mobility of vital skills and experience in cancer care across Europe.

Resolution 1 - Screening

Immediate and urgent action should be taken to ensure that cervical cancer screening programmes are not interrupted by COVID-19, especially in countries with the lowest screening rates. The adoption of HPV self-sampling must be accelerated in order to improve uptake.

Resolution 2 - Vaccination

HPV-associated cancers are preventable by universal vaccination. Anti-vaccination misinformation is putting programmes at serious risk and all European health authorities must act now to improve public confidence in HPV vaccination.

If you want to go fast, go alone. If you want to go further, go together.

We, participants of the European Cancer Summit 2020, commit ourselves to working in an open collaborative way, knowing that it is teamwork that brings the best results for cancer patients. Our global community will stand together to face the challenges ahead in our mission of combating cancer.

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired Past-President, Union for International Cancer Control, Jordan
  • Manuel Heitor Minister for Science, Technology and Higher Education, Portugal
  • Anja Karliczek Federal Minister of Education and Research, Germany
  • Simona Kustec Minister of Education, Science and Sport, Slovenia
Registration closed

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired Past-President, Union for International Cancer Control, Jordan
  • Manuel Heitor Minister for Science, Technology and Higher Education, Portugal
  • Anja Karliczek Federal Minister of Education and Research, Germany
  • Simona Kustec Minister of Education, Science and Sport, Slovenia

Working Together Against Cancer: Breaking Down Barriers & Saving Lives

The co-chairs of the European Cancer Summit 2020, Isabel Rubio and Stefan Gijssels, have worked with the co-chairs of our Focused Topic Networks to finalise a relevant and impactful programme with leading speakers. Please see full details of each session below.


Download the Programme PDF here.
For details on Resolutions, please click here

Wednesday 18 November 2020

(Timelines subject to change)

09:00-09:15  Opening Session

President of the European Cancer Organisation, Matti Aapro and Summit Co-Chairs, Isabel Rubio and Stefan Gijssels open the Summit with their introductions for the coming sessions.

09:15-10:45 Impact of COVID-19 on Cancer

No area of cancer care has been left undamaged by the impacts of COVID-19. Harm has been inflicted on prevention efforts, such as vaccination, through to screening, treatment and follow up care. While rapid catchup is required, so too is frank debate and resolution about what lessons must be learnt and applied most quickly to place Europe on a stronger footing for the likely 'next time'. We invite Europe's cancer community to join us for this critical exchange.

The Co-Chairs of our Special Network on the Impact of COVID-19 on Cancer Mirjam Crul and Mark Lawler lead this important discussion with interventions from Jens Spahn Federal Minister of Health in Germany, Bente Mikkelsen (Director for Non-communicable Diseases, World Health Organization) and Veronique Trillet-Lenoir MEP (Co-Chair of the MEPs Against Cancer Group).  Joining them in the debate will be John Ryan (Director of Public Health, DG Sante), Kathy Oliver (Co-Director of the International Brain Tumour Alliance and Vice Chair of the Patient Advisory Committee) and Nicoletta Luppi (Senior Vice President and Managing Director, MSD Italia) with moderated questions from Summit delegates.

10:45-11:00 Coffee Break

11:00-12:30 Health Systems and Treatment Optimisation 

In 2020 the European Cancer Organisation established a Health Systems and Treatment Optimisation Network with the aim of bringing about a reorientation of health systems and research approaches in cancer in order to achieve the twin aims of:

  1. Treatment optimisation: optimising cancer treatment for the benefit of the patient
  2. Health systems optimisation: optimising cancer care delivery for the benefit of the healthcare system.

Working with members of the European Cancer Organisation, patient advocates, members of Community 365 and invited experts, the Network has developed propositions to support re-engineering of approaches towards research, use of real world data and the pervading market and post market regulatory framework.

Co-Chairs Denis Lacombe and Yolande Lievens invite you to join them as they share assessments of the challenges and opportunities associated with such a reform agenda with speakers including:

  • Bengt Jonsson, Professor Emeritus of Health Economics, Stockholm School of Economics
  • Benjamin Besse, Head of the Medical Oncology Department, Institut Gustave Roussy
  • Bartosz Arlukowicz MEP, Chair of the European Parliament’s Special Committee for Beating Cancer
  • Jan Geissler, CML Advocates Network and Patient Advisory Committee member
  • Lydie Meheus, Managing Director, Anticancer Fund
12:30-13:00 Lunch

13:00-14:15 How to implement Quality Cancer Care in Europe: From good intentions to patient benefit

2020 is an eventful year for the Quality Cancer Care agenda in Europe. The run-up to the European Cancer Summit marks the publication of a new European Code of Cancer Practice, new Essential Requirements for Quality Cancer Care for Breast Cancer, Prostate Cancer and Lung Cancer, and the launch of our new Quality Cancer Care Network at the European level. The Organisation of European Cancer Institutes has also published 100 European core quality standards for cancer care and research centres and the European Cancer Organisation is now in the process of developing Essential Requirements for Quality Cancer Care for Pancreatic Cancer, Ovarian Cancer and Glioma. The European Cancer Summit will give the opportunity to not only reflect on these key developments but also to plan ahead together for an even more impactful 2021. Quality Cancer Care is everyone's concern. We invite you to bring your perspective and make your voice heard.

Co-Chairs Simon Oberst and Philip Poortmans are joined by Thierry Philip (EU Cancer Mission Assembly member and President of OECI), Frances Fitzgerald MEP, Francesca Colombo (Head of the OECD Health Division), Sema Erdem (Co-Chair of the Patient Advisory Committee) and Peter Luhrs (Therapeutic Area Head Oncology, Bayer) for focused presentation and discussion on the practical means by which European visions for cancer care can be turned into reality. In so doing, the session will give particular attention to the implementation of comprehensive cancer care infrastructures, and how better use of data can lead to results driven efficacy.

14:15-15:30 Inequalities: Disparities and Discrimination in Cancer Care

Our Inequalities Network aims to identify and highlight the existing disparities in access and delivery of evidence-based care and optimal outcomes for patients with cancer across Europe. Inequalities may discriminate against patients with cancer based on nationality, geography, ethnicity, gender, sexual orientation, age, literacy, income, availability of clinical trials and presence of disability. Inequalities are a major source of variation in cancer care for various groups of patients and should be a key topic for policy makers.

This session will provide insight into ongoing initiatives to tackle disparities in cancer care and future directions to ensure equity in cancer care across Europe.

Moderated by the Co-Chairs of our Inequalities Network, Nicolo Battisti and Hein Van Poppel, we are delighted to have a panel of speakers that will speak on different aspects of the Inequalities issue:

  • Lori J. Pierce, President of the American Society of Clinical Oncology
  • Richard Sullivan, Editor-in-Chief, Journal of Cancer Policy, and Director, Institute of Cancer Policy, King's College London
  • Robert Greene, Member of the European Cancer Organisation's Patient Advisory Committee
  • Kateřina Konečná MEP, Member of the Special Committee for Beating Cancer
  • Masum Hossain, President, International Developed Markets, Pfizer
  • Katie Reeder-Hayes, Chair, Health Equity Committee, American Society of Clinical Oncology

15:30-15:45 Coffee Break

15:45-17:00 Early Detection Saves Lives: Taking European Cooperation on Cancer Screening to the Next Level

With Europe’s Beating Cancer Plan trailed to have a distinct section devoted to improving early detection and diagnosis of cancer, how can existing European level recommendations on cancer screening achieve a better implementation in practice? What are the routes to improving quality assurance of screening? How should Europe’s Beating Cancer Plan take account of new options on screening, including risk stratified approaches? How can cost effectiveness of screening be best understood in the decision-making process?

Our Prevention Network which is led by Co-Chairs Isabel Rubio and Jan Van Meerbeeck addresses itself to such matters, with a team of experts to present and debate issues around early detection and screening, including:

  • Tit Albreht, Coordinator of the Joint Action, the Innovative Partnership for Action Against Cancer – IPAAC
  • Partha Basu, Head, Screening Group, International Agency for Research on Cancer, World Health Organisation
  • Dolors Montserrat MEP, Member of the European Parliament’s Special Committee on Cancer
  • Harry De Koning, Professor of Public Health & Screening Evaluation, Erasmus MC University
  • Stefan Gijssels, Co-Chair, Patient Advisory Committee and Chief Executive Officer of Digestive Cancers Europe
  • Padraic Ward, Head of Commercial Operations, Roche

17:00-18:00 Europe’s Beating Cancer Plan

Stella Kyriakides, EU Commissioner for Health and Food Safety will join the @EuropeanCancer community to share the latest progress on Europe’s Beating Cancer Plan, due to be finalised before the end of 2020.  This follows months of consultation after the launch of the Plan at the EU Parliament on World Cancer Day, 4 February 2020.  The plan should provide actions to accelerate and improve country coordination in combatting cancer. The European Cancer Summit 2020 is ideally timed to hear the latest information about the plan and to discuss together its implementation in 2021.  

In addition, the National Ministers responsible for Research in Portugal, Germany and Slovenia will participate with their contribution on how Europe’s Beating Cancer Plan can be supported by their EU Presidency in the context of Research.  We look forward to hearing from Manuel Heitor, Minister for Science, Technology and Higher Education in Portugal, Anja Karliczek, Federal Minister of Education and Research in Germany, and Simona Kustec, Minister of Education, Science and Sport in Slovenia during this session.

The Commissioner will be joined “on stage” by the European Cancer Organisation’s Executive Committee, as well as the co-chairs of this year’s Summit, for comment and discussion.

 

Thursday 19 November 2020
09:00-10:30 Mission-Driven Cancer Research: All Together as One

The European Cancer Summit will shine a spotlight on the concluding work of the European Cancer Mission Board, ahead of the formal commencement of the EU Cancer Mission in 2021.

The session will open with a keynote address from Mariya Gabriel, EU Commissioner for Innovation, Research, Culture, Education and Youth, in which the overall approach of the European Commission 2019-24 towards cancer research will be outlined.

Thereafter, moderated by Matti Aapro, President of the European Cancer Organisation and Member of the Cancer Mission Assembly, panelists will explore key targets and actions of the forthcoming Mission, including its focus on areas such as Prevention, Quality of Life and Survivorship and other major challenges to be tackled within its programme of action.

Panelists include:

  • Walter Ricciardi, Chair of the EU Cancer Mission Board
  • Manfred Weber MEP, Chairman of the EPP Group in the European Parliament
  • Christine Chomienne, Vice-Chair of the EU Cancer Mission Board
  • Bettina Ryll, Member of the EU Cancer Mission Board and Founder of the Melanoma Patient Network Europe
  • Caroline Dive, President of the European Association for Cancer Research
  • Nathalie Moll, Director General at European Federation of Pharmaceutical Industries and Associations


10:30-10:45 Coffee Break

10:45-12:00 Cancer Survivorship: the Physical and Psycho-Social Legacies

The inclusion of a specific section of Europe's Beating Cancer Plan dedicated to Survivorship and Quality of Life issues represented a landmark in confirming the high political recognition this agenda has now achieved. Supporting this, our Survivorship and Quality of Life Network is devoted to pushing policy-makers to go further faster in tackling issues such as discrimination against cancer patients and survivors, providing better quality supportive care and to beating cancer stigma and fear.

Building on the Network’s focus on both physical and psycho-social needs of cancer patients and survivors, Co-Chairs Andrew Davies and Csaba Degi will lead this session including presentations on:

  • Psychosocial and behavioral issues: addressing the challenges of cancer survivorship with Anja Mehnert, Head of Psychosocial Oncology, Department of Medical Psychology and Medical Sociology, University Medical Center Leipzig
  • Physical symptoms in cancer survivors – the “iceberg” phenomenon with Andrew Davies, President of the Multinational Association of Supportive Care in Cancer (MASCC)

and a discussion with:

  • Janina Ochojska MEP, herself a breast cancer survivor
  • Alexander Zehnder, Global Head of Oncology, Sanofi
  • Sarunas Narbutas, Chairman, Youth Cancer Europe

The session will end with an update from Francoise Meunier (Vice President, Federation Of European Academies Of Medicine) on progress made since the resolution passed at the European Cancer Summit in 2018 on Financial Discrimination and the “Right to be Forgotten” which, thanks to Francoise’s leadership, has already been adopted by some European countries.

12:00-12:45 Lunch 

12:45-14:00 Preparing a Resilient Oncology Workforce for the Present and Future

Without a workforce you have no cancer care. Continual policy attention must be provided to such matters as education and training, labour mobility, professional qualification recognition and addressing workforce shortages. Europe has a role in all these areas. Yet it appears far from clear that, to date, this role has met its full potential.

Opening with a Conversation with Nicolas Schmit, European Commissioner for Employment, Social Affairs And Inclusion, the session will then hear expert perspectives and responses from Nicolás González Casares, a nurse and Member of the European Parliament; Lynda Wyld, Professor of Surgical Oncology at the University of Sheffield; Kathi Apostolidis, President of the European Cancer Patient Coalition (ECPC); and, Alexandru Eniu, Chair of the College of the European School of Oncology.

Moderated by Workforce Network Co-Chairs, Andreas Charalambous (EONS), Mirjam Crul (ESOP) and Geerard Beets (ESSO), the session builds in open opportunity for exchange with the audience before inviting attendees to participate in the agreement of Network resolution on the topic of professional qualification recognition.

14:00-15:15 Viral Protection: Achieving the Possible. The elimination of HPV cancers in Europe

2020 is the year when the global community committed itself to the elimination of a cancer caused almost entirely by HPV through the World Health Organization’s new cervical cancer strategy. What will be Europe's role in this global effort and can it go further and achieve the elimination of all the cancers caused by HPV?

The HPV Action Network, led by Daniel Kelly and  Rui Medeiros has been working hard on the issues around vaccination, screening, treatment and awareness of HPV and in October 2020 produced a report (Viral Protection: Achieving the Possible. A Four Step Plan for Eliminating HPV Cancers in Europe). They will lead this session which will include:

Andrea Ammon, Director General of the European Centre for Disease Prevention and Control (ECDC), speaking on ‘Time for Action: Overcoming the barriers to HPV cancer elimination’

There will also be presentations and discussions on:

An HPV cancer free Europe by 2030: Is it really possible?
  • Margaret Stanley, President, International Papillomavirus Society (IPVS)
Advocating for HPV cancer elimination: the role of civil society organisations
  • Tristan Almada, Co-Founder, HPV and Anal Cancer Foundation and the Noman Is An Island: Race to End HPV Campaign
  • Cobi Reisman, Past President, European Society for Sexual Medicine (ESSM)
Meeting the challenge of ‘fake news’ head on
  • Emilie Karafillakis, European Research Lead, Vaccine Confidence Project, London School of Hygiene and Tropical Medicine

Alessandra Moretti MEP, Member, Special Committee on Beating Cancer, will join the panel to discuss how Europe’s Beating Cancer Plan can make a real difference in HPV elimination.

Members of the HPV Action Network around Europe will be in the audience contributing to the debate.

15:15-15:30 Coffee Break

15:30-17:00 The Digital Transformation of Cancer Care

10, 20 and 30 years from now, how will technology have changed cancer care? What preparations for those futures should we already be making? What technologies already at our fingertips are we failing to make best use of? While the sense of urgency in the cancer community about embracing the powers of new technology for better treatment and care grows, persistent barriers remain. What opportunities are presently available to get past these?

Led by our Digital Health Network, this session will hear experience from leading experts, share perspectives from a range of stakeholders on key controversies and open new horizons for attendees about the coming possibilities.

Keynote presentations will examine the current status of cancer care’s transformation by digital technology from the perspectives of the clinician, the world of biomedical informatics, as well as imaging.

Join our Digital Health Network co-Chairs Regina Beets-Tan and Wim Oyen, as they unlock the crucial points of debate with:

  • Fred Prior, Professor and Chair, Department of Biomedical Informatics, University of Arkansas
  • Wiro Niessen, Professor in Biomedical Image Analysis, Erasmus MC/TU Delft
  • Gilly Spurrier-Bernard, Melanoma Patient Network Europe
  • Sara Cerdas MEP, Shadow Rapporteur, Eu4Health; Vice Chair of the Special Committee on Beating Cancer and Co-Chair, ENVI Committee Health Working Group
  • Anastassia Negrouk, Chief Operating Officer, MyData-TRUST
  • Christian Stoeckigt, Head of Scientific Affairs & Medical Education, Hologic

Audience members too will be key participants as a lively exchange is expected on the controversies and points of solution!


17:00-18:00 Cancer Issues Worldwide

Matti Aapro, President of the European Cancer Organisation will moderate a discussion on the most important issues in cancer facing the world today, with a panel of experts from around the world including:

  • Hans Kluge, Regional Director for Europe, World Health Organization (WHO)
  • HRH Princess Dina Mired, Past-President of the Union for International Cancer Control (UICC)
  • Lori Pierce, President of the American Society of Clinical Oncology (ASCO)
  • Franco Cavalli, Chair of the World Oncology Forum
  • Catherine Owen, Senior Vice President, Major Markets, Bristol-Myers Squibb (BMS)

18:00-18:15 Closing Session

President of the European Cancer Organisation, Matti Aapro and Summit Co-Chairs, Isabel Rubio and Stefan Gijssels close the Summit with their observations from the previous sessions.

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired Past-President, Union for International Cancer Control, Jordan
  • Manuel Heitor Minister for Science, Technology and Higher Education, Portugal
  • Anja Karliczek Federal Minister of Education and Research, Germany
  • Simona Kustec Minister of Education, Science and Sport, Slovenia

Speakers

  • Stella Kyriakides European Commissioner for Health and Food Safety (DG SANTE)
  • Jens Spahn Federal Health Minister, Germany
  • HRH Princess Dina Mired Past-President, Union for International Cancer Control, Jordan
  • Manuel Heitor Minister for Science, Technology and Higher Education, Portugal
  • Anja Karliczek Federal Minister of Education and Research, Germany
  • Simona Kustec Minister of Education, Science and Sport, Slovenia